Drugs News and Research

RSS

Study finds shortcomings in long-term care for heart failure patients in the UK

Management of people with heart failure in the UK has shortcomings in screening, continuity of care, and medication doses, which disproportionally impact women and older people, according to a study led by Nathalie Conrad and Kazem Rahimi of The George Institute for Global Health at the University of Oxford, UK, published May 21 in PLOS Medicine.

22 May 2019

New fluorescent sensor can detect migrating cancer cells

A new fluorescent sensor developed by researchers from the University of Adelaide can detect migrating cancer cells and could be used to target medication to stop metastasis in aggressive cancers.

22 May 2019

Southern Research team aims to discover new, safer antimalarial medicines

Scientists at Southern Research's Drug Discovery division have joined the fight against malaria through efforts aimed at discovering new drugs and improving the safety and efficacy of current antimalarial medicines.

22 May 2019

Neonatal exposure to nicotine alters neurons, predisposes brain to addiction in adulthood

Neonatal exposure to nicotine alters the reward circuity in the brains of newborn mice, increasing their preference for the drug in later adulthood, report researchers at University of California San Diego School of Medicine in a study published "in press" April 24, 2019 in Biological Psychiatry.

22 May 2019

Developing biosecurity tool to detect engineered microorganisms based on DNA signatures

If a genetically or synthetically engineered organism is released into the environment, how will we know?

22 May 2019

Research uncovers potential breakthrough in the understanding of tumor dormancy

Scientists at VCU Massey Cancer Center may have uncovered a primary method through which cancer cells exist undetected in an organism and received more than $1 million to investigate the potential for novel therapeutics that target and destroy cells in a specific state of tumor dormancy.

22 May 2019

Pediatric cancer patients wait an average of 6.5 years longer than adults to access new drugs

Cancer drugs approved by the U.S. Food and Drug Administration took a median of 6.5 years to go from the first clinical trial in adults to the first trial in children, according to a study at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

22 May 2019

New opioid accelerates recovery and prevents relapse to chronic pain

Morphine and other opioid-based painkillers are very effective at treating pain initially, but studies have shown that the drugs can make patients more pain-sensitive, prolonging their discomfort and increasing their risks of developing chronic pain.

22 May 2019

Cannabis could help people with opioid addiction

A new study has shown that cannabidiol or CBD, found in cannabis, could help people with opioid use disorder or addiction. CBD can help reduce the symptoms of craving among addicts when on withdrawal from the opioid and also reduce the accompanying anxiety and restlessness write the authors of the study.

22 May 2019

New cell co-culture platform holds promise for future of personalized medicine

Why doesn't the same treatment work in the same way for every patient?

22 May 2019

New study shows how a kidney biopsy can be used to tailor treatment for lupus patients

The kidneys of patients living with systemic lupus erythematosus are often under assault, and not all those living with the disease will respond to standard treatment.

21 May 2019

Study helps explain why lack of sleep is bad for the heart

In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack.

21 May 2019

Distractions and exercise may be key to managing chronic pain

A man who developed scoliosis as a teenager has developed ways to cope with chronic pain without using pain medication.

21 May 2019

Researchers explore link between aging fat cells and Alzheimer's

Scientists want to know whether our aging fat cells are important to the onset and progression of Alzheimer's.

21 May 2019

Virtual clinical trial: Improving methadone dosage for drug users with TB to prevent withdrawal symptoms

Drug users on methadone programs who contract tuberculosis should receive effective treatment while maintaining the correct level of methadone in their bodies, following a virtual clinical trial by pharmacy researchers at Aston University in partnership with drugs charity Addaction.

21 May 2019

Drugs News and Research

Study finds shortcomings in long-term care for heart failure patients in the UK

New fluorescent sensor can detect migrating cancer cells

Southern Research team aims to discover new, safer antimalarial medicines

Neonatal exposure to nicotine alters neurons, predisposes brain to addiction in adulthood

Developing biosecurity tool to detect engineered microorganisms based on DNA signatures

Research uncovers potential breakthrough in the understanding of tumor dormancy

Pediatric cancer patients wait an average of 6.5 years longer than adults to access new drugs

New opioid accelerates recovery and prevents relapse to chronic pain

Cannabis could help people with opioid addiction

New cell co-culture platform holds promise for future of personalized medicine

New study shows how a kidney biopsy can be used to tailor treatment for lupus patients

Study helps explain why lack of sleep is bad for the heart

Distractions and exercise may be key to managing chronic pain

Researchers explore link between aging fat cells and Alzheimer's

Virtual clinical trial: Improving methadone dosage for drug users with TB to prevent withdrawal symptoms

Why Missouri’s the last holdout on a statewide Rx monitoring program

New approach to waking up sleeping genes could help people with Prader-Willi syndrome

Opioid prescriptions drop sharply among state workers

PDIA1 enzyme levels could help diagnose individuals’ predisposition to cardiovascular disease

Study explains why several clinical trials of treatments for sepsis have been failed

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News